( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Fouzia Farheen* and Dr. G. Jyothilakshmi


Background: Candidiasis is the most common vaginal infection affecting approximately 75% of reproductive age group women. Rapid identification of yeast isolates to species level is essential to optimize antifungal treatment. Aim: To identify the species of Candida from patients of vaginitis and to study antifungal susceptibility pattern of isolated candida species. Methods: Vaginal swabs were collected from women in the reproductive age groups who attended STD clinic with clinically diagnosed vaginitis during the months of June 2019 to December 2019. The swabs were inoculated onto SDA. 91 candida were isolated. Isolated colonies of candida were inoculated onto CHROM agar & species were identified by color of the colonies produced as per manufacturer chart. Colonies also inoculated onto corn meal agar for chlamydospore formation. Antifungal susceptibility was done by disc diffusion method. Results: A total of 150 women of reproductive age group who were clinically diagnosed to have Vaginal Candidiasis were included in the study. Out of 150 vaginitis patients, 91 were positive for Candida species. All the isolates were speciated comprising 4 species. C. albicans - 42 (46.1%), C. glabrata - 41 (45.1%), C. Krusei - 5 (5.5%) and C. tropicalis - 3 (3.3%). Antifungal susceptibility testing result of all Candida isolates - 100% susceptible to amphotericin B, nystatine, flucytocine, voriconazole, ketoconazole. All the Candida isolates except C. krusei were sensitive to fluconazole. C. krusei showed 100% resistance to fluconazole. Discussion: In the present study, C. albicans is most common species (46.1%) followed by C. glabrata. C. albicans adhere to vaginal epithelial cells in significant higher number than other Candida species this could explain relative higher frequency of C. albicans in vaginal Candidiasis. Conclusion: Presumptive identification followed by confirmation of Candida species helps to initiate early appropriate antifungal treatment there by reducing the morbidity and mortality.

Keywords: Vulvovaginal Candidiasis, Vaginitis, Non albicans candida, Antifungal susceptibility.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 June 2024 Issue has been Published, Kindly check it on


    JUNE 2024 issue has been successfully launched on JUNE 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia